- Home
- Software Solutions
- Resources
- Corporate
A Study to Evaluate Corrected QT Interval From Clinical Studies Conducted With Bevacizumab
Sponsors:
| Phases:
| |
| Indications | Acronym: | |
| ||
Age Groups:
| Gender: Both | |
| Names: | Enrollment: 150 | |
Additional information about NCT00477425.